Athira Pharma, Inc. - stock earnings
ATHA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -27285 USD | ? USD |
| 2023Q3 | -33.0 million USD | ? USD |
| 2023Q2 | -29.6 million USD | ? USD |
| 2023Q1 | -25.9 million USD | ? USD |
| 2022Q4 | -25.7 million USD | ? USD |
| 2022Q3 | -16.2 million USD | ? USD |
| 2022Q2 | -23.8 million USD | ? USD |
| 2022Q1 | -18.6 million USD | ? USD |
| 2021Q4 | -16.3 million USD | ? USD |
| 2021Q3 | -15.7 million USD | ? USD |
| 2021Q2 | -14.0 million USD | ? USD |
| 2021Q1 | -8.9 million USD | ? USD |
| 2020Q4 | -7.7 million USD | ? USD |
| 2020Q3 | -8.5 million USD | ? USD |
| 2020Q2 | -2.0 million USD | ? USD |
| 2020Q1 | -1.8 million USD | ? USD |
| 2019Q4 | -974000 USD | ? USD |
| 2019Q3 | -1.5 million USD | ? USD |
ATHA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -117672 USD | ? USD |
| 2022 | -87.3 million USD | ? USD |
| 2021 | -54.4 million USD | ? USD |
| 2020 | -18.6 million USD | ? USD |
| 2019 | -4.7 million USD | ? USD |
| 2018 | -5.1 million USD | ? USD |
ATHA
Price: $2.16
52 week price:
Earnings Per Share: -3.09 USD
P/E Ratio: -0.98
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 290900
Market Capitalization: 75.5 million